Profil
Liu Song Yin is currently Director at Sunho Bio Investments Ltd., Sunho Hk Ltd., Sunho Pharmaceutical Technology Zhejiang Anji Co. Ltd., and Nanjing Sunho Medical Technology Co., Ltd. Since 2020, Dr. Yin has been Chief Executive & Scientific Officer at SunHo (China) Biopharmaceutical Co. Ltd. Former positions include Director, Co-Chief Executive & Scientific Officer at Sunho Biologics, Inc. from 2023 to 2026, and Executive Director at Genscript Biotech Corp.
from 2015 to 2020.
Education includes an undergraduate degree from the University of Science & Technology of China in 2008 and a doctorate from UMass Chan Medical School in 2014.
Postes actifs de Liu Song Yin
| Sociétés | Poste | Début |
|---|---|---|
SunHo (China) Biopharmaceutical Co. Ltd. | Directeur Général | 01/11/2020 |
Anciens postes connus de Liu Song Yin
| Sociétés | Poste | Fin |
|---|---|---|
| SUNHO BIOLOGICS, INC. | Directeur Général | 28/02/2026 |
| GENSCRIPT BIOTECH CORPORATION | Directeur/Membre du Conseil | 01/10/2020 |
Formation de Liu Song Yin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genscript Biotech Corp.
Genscript Biotech Corp. BiotechnologyHealth Technology Manufactures biological products and provides life science research services | Health Technology |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Engages in development and commercialization of biologics | Health Technology |
SunHo (China) Biopharmaceutical Co. Ltd. |
















